Spania -
spansk -
AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)
sugammadex normon 100 mg/ml solucion inyectable efg
laboratorios normon s.a. - sugammadex sodio - soluciÓn inyectable - 100 mg/ml inyectable 5 ml - sugammadex sodio 100 mg - sugammadex
Spania -
spansk -
AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)
sugammadex glenmark 100 mg/ml solucion inyectable efg
glenmark arzneimittel gmbh - sugammadex sodio - soluciÓn inyectable - 100 mg/ml inyectable 5 ml - sugammadex sodio 100 mg - sugammadex
Spania -
spansk -
AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)
sugammadex tarbis 100 mg/ml solucion inyectable efg
tarbis farma s.l. - sugammadex sodio - soluciÓn inyectable - 100 mg/ml inyectable 5 ml - sugammadex sodio 100 mg - sugammadex
Spania -
spansk -
AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)
sugammadex baxter 100 mg/ml solucion inyectable efg
baxter holding b.v. - sugammadex - soluciÓn inyectable - 100 mg/ml inyectable 5 ml - sugammadex 100 mg - sugammadex
Den europeiske union -
slovakisk -
EMA (European Medicines Agency)
sugammadex mylan
mylan ireland limited - sugammadex sodium - neuromuskulárna blokáda - všetky ostatné terapeutické produkty - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
Den europeiske union -
finsk -
EMA (European Medicines Agency)
sugammadex piramal
piramal critical care b.v. - sugammadex sodium - neuromuskulaarinen estäminen - sugammadeksi - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults.
Den europeiske union -
rumensk -
EMA (European Medicines Agency)
sugammadex adroiq
extrovis eu ltd. - sugammadex sodium - blocaj blocant - toate celelalte produse terapeutice - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
Den europeiske union -
dansk -
EMA (European Medicines Agency)
sugammadex fresenius kabi
fresenius kabi deutschland gmbh - sugammadex sodium - neuromuskulær blokade - alle andre terapeutiske produkter - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
Den europeiske union -
dansk -
EMA (European Medicines Agency)
sugammadex adroiq
extrovis eu ltd. - sugammadex sodium - neuromuskulær blokade - alle andre terapeutiske produkter - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
Den europeiske union -
svensk -
EMA (European Medicines Agency)
sugammadex adroiq
extrovis eu ltd. - sugammadex sodium - neuromuskulär blockade - alla andra terapeutiska produkter - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.